Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Moreau

Showing results (401-410 of 447) with videos related to

Pageof 45
Sort By:
Bone Marrow Transplantation|June 26, 2010
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patientsV Roland, C Bodet-Milin, A Moreau, et al.
BMJ Open|April 29, 2022
Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilotLauren A Moreau, Ivana Holloway, Beth Fylan, et al.
Translational Psychiatry|February 14, 2024
Pervasive alterations of intra-axonal volume and network organization in young children with a 16p11.2 deletionAnne M Maillard, David Romascano, Julio E Villalón-Reina, et al.
Der Orthopade|February 13, 2009
[Molecular and genetic aspects of idiopathic scoliosis. Blood test for idiopathic scoliosis]A Moreau, M-Y Akoumé Ndong, B Azeddine, et al.
American Journal of Clinical Pathology|November 5, 1998
Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS)S Camilleri-Broët, A Martin, A Moreau, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2024
H<sub>2</sub> inhalation therapy in patients with moderate COVID-19 (H<sub>2</sub>COVID): a prospective ascending-dose phase I clinical trialC Salomez-Ihl, J Giai, M Barbado, et al.
Nature. Mental Health|July 14, 2025
Neuroimaging insights into brain mechanisms of early-onset restrictive eating disordersClara A Moreau, Anael Ayrolles, Christopher R K Ching, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2014
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single centerM Loirat, P Chevallier, C Leux, et al.
Nature Medicine|June 28, 2011
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibitionNeil Johnson, Yu-Chen Li, Zandra E Walton, et al.
Annals of Hematology|June 15, 2016
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experienceJ Bourcier, T Gastinne, C Leux, et al.
Pageof 45

Showing results (401-410 of 447) with videos related to

Sort By:
Pageof 45
Bone Marrow Transplantation|June 26, 2010
Impact of high-dose chemotherapy followed by auto-SCT for positive interim [18F] FDG-PET diffuse large B-cell lymphoma patientsV Roland, C Bodet-Milin, A Moreau, et al.
BMJ Open|April 29, 2022
Using routine healthcare data to evaluate the impact of the Medicines at Transitions Intervention (MaTI) on clinical outcomes of patients hospitalised with heart failure: protocol for the Improving the Safety and Continuity Of Medicines management at Transitions of care (ISCOMAT) cluster randomised controlled trial with embedded process evaluation, health economics evaluation and internal pilotLauren A Moreau, Ivana Holloway, Beth Fylan, et al.
Translational Psychiatry|February 14, 2024
Pervasive alterations of intra-axonal volume and network organization in young children with a 16p11.2 deletionAnne M Maillard, David Romascano, Julio E Villalón-Reina, et al.
Der Orthopade|February 13, 2009
[Molecular and genetic aspects of idiopathic scoliosis. Blood test for idiopathic scoliosis]A Moreau, M-Y Akoumé Ndong, B Azeddine, et al.
American Journal of Clinical Pathology|November 5, 1998
Primary central nervous system lymphomas in 72 immunocompetent patients: pathologic findings and clinical correlations. Groupe Ouest Est d'étude des Leucénies et Autres Maladies du Sang (GOELAMS)S Camilleri-Broët, A Martin, A Moreau, et al.
Antimicrobial Agents and Chemotherapy|July 17, 2024
H<sub>2</sub> inhalation therapy in patients with moderate COVID-19 (H<sub>2</sub>COVID): a prospective ascending-dose phase I clinical trialC Salomez-Ihl, J Giai, M Barbado, et al.
Nature. Mental Health|July 14, 2025
Neuroimaging insights into brain mechanisms of early-onset restrictive eating disordersClara A Moreau, Anael Ayrolles, Christopher R K Ching, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2014
Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single centerM Loirat, P Chevallier, C Leux, et al.
Nature Medicine|June 28, 2011
Compromised CDK1 activity sensitizes BRCA-proficient cancers to PARP inhibitionNeil Johnson, Yu-Chen Li, Zandra E Walton, et al.
Annals of Hematology|June 15, 2016
Rituximab maintenance after autologous stem cell transplantation prolongs response duration in non-naive rituximab follicular lymphoma patients: a single institution experienceJ Bourcier, T Gastinne, C Leux, et al.
Pageof 45